The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stephenson, L.
Right arrow Articles by Boothby, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stephenson, L.
Right arrow Articles by Boothby, M.
The Journal of Immunology, 2004, 173: 4523-4528.
Copyright © 2004 by The American Association of Immunologists

An IL-4R{alpha} Allelic Variant, I50, Acts as a Gain-of-Function Variant Relative to V50 for Stat6, But Not Th2 Differentiation1

Linda Stephenson, Mary H. Johns, Emily Woodward, Ana L. Mora2 and Mark Boothby3

Department of Microbiology and Immunology, Vanderbilt University Medical School, Nashville, TN 37232

Signaling through the IL-4R {alpha}-chain (IL-4R{alpha}) is crucial for the development of Th2 cells, central effectors in atopic disease. Alleles of the IL-4R{alpha} have been identified that have been variably associated with increased incidence of allergic disease, but there is little direct evidence that any variant is sufficient to alter a target that determines allergic pathophysiology or susceptibility. Variants of IL-4R{alpha} encoding isoleucine instead of valine at position 50 (I50 vs V50, respectively) can signal increased Stat6-dependent transcriptional activity, whether in an I50, Q551 or I50, R551 haplotype. Strikingly, signaling through these receptors did not increase the efficiency of Th2 development or the IL-4 mediated repression of Th1 development or a target gene, IL-18R{alpha}. Further, IL-4-induced proliferation was similar for Th2 cells independent of the variant expressed. Together these findings indicate that IL-4R{alpha} variants that exhibit gain-of-function with respect to Stat6 do not act directly through alterations in Th2/Th1 induction after Ag exposure. The data further suggest that for such variants, any mechanistic involvement is based on a role in cellular targets of Th2 cytokines.




This article has been cited by other articles:


Home page
Ann OncolHome page
N. Schoof, F. von Bonin, S. Zeynalova, M. Ziepert, W. Jung, M. Loeffler, M. Pfreundschuh, L. Trumper, and D. Kube
Favorable impact of the interleukin-4 receptor allelic variant I75 on the survival of diffuse large B-cell lymphoma patients demonstrated in a large prospective clinical trial
Ann. Onc., September 1, 2009; 20(9): 1548 - 1554.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Q. Ford, N. M. Heller, L. Stephenson, M. R. Boothby, and A. D. Keegan
An Atopy-Associated Polymorphism in the Ectodomain of the IL-4R{alpha} Chain (V50) Regulates the Persistence of STAT6 Phosphorylation
J. Immunol., August 1, 2009; 183(3): 1607 - 1616.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
A. Acacia de Sa Pinheiro, A. Morrot, S. Chakravarty, M. Overstreet, J. H. Bream, P. M. Irusta, and F. Zavala
IL-4 induces a wide-spectrum intracellular signaling cascade in CD8+ T cells
J. Leukoc. Biol., April 1, 2007; 81(4): 1102 - 1110.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
F. Zhang and M. Boothby
T helper type 1-specific Brg1 recruitment and remodeling of nucleosomes positioned at the IFN-{gamma} promoter are Stat4 dependent
J. Exp. Med., June 12, 2006; 203(6): 1493 - 1505.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. M. Stephenson, D.-S. Park, A. L. Mora, S. Goenka, and M. Boothby
Sequence Motifs in IL-4R{alpha} Mediating Cell-Cycle Progression of Primary Lymphocytes
J. Immunol., October 15, 2005; 175(8): 5178 - 5185.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2004 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2004 by The American Association of Immunologists, Inc. All rights reserved.